Tanmoy Mondal

Affiliations reported with papers

Linked publications

An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilities 2026

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy 2025

Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer 2023

A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle 2022

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors 2021

Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies 2021

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody 2020

Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer 2020

Related research

Human FasL, evolution and plasmin cleavage

A macaque TIGIT shedding difference

The regulatory Fas epitope

DR5 agonism and PD-L1 immune evasion

Surface charge and DR5 antibody response

TRIM37 in breast-cancer outcomes

Furin disruption in SARS-CoV-2 models